KEGG   PATHWAY: mmur04934
Entry
mmur04934                   Pathway                                
Name
Cushing syndrome - Microcebus murinus (gray mouse lemur)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
mmur04934  Cushing syndrome
mmur04934

Organism
Microcebus murinus (gray mouse lemur) [GN:mmur]
Gene
105855914  CRH; corticoliberin [KO:K05256]
105863672  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
105855107  CRHR2; corticotropin-releasing factor receptor 2 [KO:K04579]
105874518  guanine nucleotide-binding protein G(s) subunit alpha isoforms short isoform X1 [KO:K04632]
105874520  neuroendocrine secretory protein 55-like [KO:K04632]
105870668  ADCY1; LOW QUALITY PROTEIN: adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
105859934  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
105884349  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
105866617  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
105879870  ADCY5; LOW QUALITY PROTEIN: adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
105867497  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
105884745  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
105882731  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
105859653  ADCY9; adenylate cyclase type 9 isoform X2 [KO:K08049] [EC:4.6.1.1]
105867963  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
105861780  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X2 [KO:K04345] [EC:2.7.11.11]
105864304  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
105865052  ATF2; LOW QUALITY PROTEIN: cyclic AMP-dependent transcription factor ATF-2 [KO:K04450]
105858535  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
105873936  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
105874305  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
105885209  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 isoform X1 [KO:K09048]
105885942  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 [KO:K09048]
105859108  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
105855129  cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
105858143  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
105878491  MEN1; menin isoform X1 [KO:K14970]
105870390  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
105868585  RBBP5; retinoblastoma-binding protein 5 isoform X2 [KO:K14961]
105879886  WDR5B; WD repeat-containing protein 5B [KO:K14963]
105880815  WDR5; WD repeat-containing protein 5 [KO:K14963]
105876097  KMT2A; LOW QUALITY PROTEIN: histone-lysine N-methyltransferase 2A [KO:K09186] [EC:2.1.1.354]
105869278  KMT2D; histone-lysine N-methyltransferase 2D isoform X1 [KO:K09187] [EC:2.1.1.354]
105877534  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
105874193  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
105874194  cyclin-dependent kinase inhibitor 2A [KO:K06621]
105877995  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
105879410  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
105867511  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
105855966  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
105866012  E2F1; transcription factor E2F1 [KO:K17454]
105863547  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
105865199  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
105861979  RASD1; dexamethasone-induced Ras-related protein 1 isoform X1 [KO:K07843]
105874990  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
105864008  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
105879338  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
105880194  AHR; aryl hydrocarbon receptor [KO:K09093]
105867505  AIP; AH receptor-interacting protein isoform X1 [KO:K17767]
105879129  AIPL1; aryl-hydrocarbon-interacting protein-like 1 [KO:K17767]
105873069  ARNT; LOW QUALITY PROTEIN: aryl hydrocarbon receptor nuclear translocator [KO:K09097]
105876702  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
105864946  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
105875662  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
105877006  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
105861439  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
105861596  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C isoform X1 [KO:K04850]
105875072  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
105856433  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F isoform X1 [KO:K04853]
105859992  CACNA1S; LOW QUALITY PROTEIN: voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
105868864  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
105885735  calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
105879489  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X2 [KO:K04515] [EC:2.7.11.17]
105858406  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
105878770  RAP1A; ras-related protein Rap-1A isoform X1 [KO:K04353]
105880992  RAP1B; ras-related protein Rap-1b [KO:K07836]
105873244  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
105868083  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
105873938  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
105870697  mitogen-activated protein kinase 6-like [KO:K04371] [EC:2.7.11.24]
105877796  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
105871124  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
105870310  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
105877217  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
105870713  USP8; ubiquitin carboxyl-terminal hydrolase 8 isoform X1 [KO:K11839] [EC:3.4.19.12]
105884309  POMC; pro-opiomelanocortin [KO:K05228]
105861032  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
105880116  MRAP; LOW QUALITY PROTEIN: melanocortin-2 receptor accessory protein [KO:K22398]
105870579  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1 [KO:K18437] [EC:3.1.4.53]
105856524  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
105883021  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform X1 [KO:K13298] [EC:3.1.4.17 3.1.4.35]
105875180  NR5A1; steroidogenic factor 1 [KO:K08560]
105870777  SP1; transcription factor Sp1 [KO:K04684]
105868051  PBX1; pre-B-cell leukemia transcription factor 1 isoform X2 [KO:K09355]
105874387  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
105870391  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
105855431  NCEH1; neutral cholesterol ester hydrolase 1 isoform X2 [KO:K14349] [EC:3.1.1.-]
105871031  ARMC5; armadillo repeat-containing protein 5 isoform X1 [KO:K22499]
105856439  AGT; angiotensinogen [KO:K09821]
105881238  AGTR1; type-1 angiotensin II receptor [KO:K04166]
105868697  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
105873966  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
105861219  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
105878468  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
105872433  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
105880040  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 [KO:K05858] [EC:3.1.4.11]
105869384  ITPR1; LOW QUALITY PROTEIN: inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
105857276  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
105861402  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
105880580  KCNK2; potassium channel subfamily K member 2 isoform X1 [KO:K04913]
105885120  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
105859583  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H isoform X1 [KO:K04855]
105858532  voltage-dependent T-type calcium channel subunit alpha-1I isoform X1 [KO:K04856]
105880911  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
105867792  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
105884378  KCNK3; potassium channel subfamily K member 3 isoform X1 [KO:K04914]
105885441  LDLR; LOW QUALITY PROTEIN: low-density lipoprotein receptor [KO:K12473]
105880850  SCARB1; scavenger receptor class B member 1 isoform X1 [KO:K13885]
105862155  cholesterol side-chain cleavage enzyme, mitochondrial isoform X1 [KO:K00498] [EC:1.14.15.6]
105869786  HSD3B2; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 isoform X1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
105858145  steroid 21-hydroxylase isoform X1 [KO:K00513] [EC:1.14.14.16]
105878054  fumarate hydratase, mitochondrial-like [KO:K01679] [EC:4.2.1.2]
105863788  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
105869202  WNT1; proto-oncogene Wnt-1 [KO:K03209]
105869373  WNT2; protein Wnt-2 isoform X1 [KO:K00182]
105878754  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
105863673  WNT3; proto-oncogene Wnt-3 [KO:K00312]
105873607  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
105861590  WNT5B; protein Wnt-5b isoform X1 [KO:K00444]
105864858  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
105857713  WNT6; protein Wnt-6 isoform X1 [KO:K00445]
105867344  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
105864522  WNT7A; protein Wnt-7a isoform X1 [KO:K00572]
105862521  WNT8A; protein Wnt-8a isoform X3 [KO:K00714]
105873639  WNT8B; protein Wnt-8b isoform X1 [KO:K00714]
105883515  WNT9B; protein Wnt-9b [KO:K01064]
105878831  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
105881062  protein Wnt-9b [KO:K01064]
105868496  WNT10B; protein Wnt-10b [KO:K01357]
105857652  WNT10A; protein Wnt-10a [KO:K01357]
105860401  WNT11; protein Wnt-11 [KO:K01384]
105867353  WNT16; protein Wnt-16 [KO:K01558]
105856944  FZD7; frizzled-7 [KO:K02432]
105879391  FZD1; frizzled-1 [KO:K02432]
105883521  FZD2; frizzled-2 [KO:K02235]
105877164  FZD3; LOW QUALITY PROTEIN: frizzled-3 [KO:K02329]
105860427  FZD4; frizzled-4 [KO:K02354]
105864316  FZD5; frizzled-5 [KO:K02375]
105871982  FZD8; LOW QUALITY PROTEIN: frizzled-8 [KO:K02375]
105882153  FZD6; frizzled-6 isoform X1 [KO:K02376]
105872762  FZD10; frizzled-10 [KO:K02842]
105858813  FZD9; frizzled-9 [KO:K02842]
105877644  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
105855775  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
105877972  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
105879917  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
105856263  AXIN1; axin-1 isoform X1 [KO:K02157]
105861654  AXIN2; axin-2 isoform X1 [KO:K04385]
105874413  CTNNB1; catenin beta-1 [KO:K02105]
105860762  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
105870856  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
105869975  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
105876584  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
105875160  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
105872329  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
mmur00020  Citrate cycle (TCA cycle)
mmur00140  Steroid hormone biosynthesis
mmur04020  Calcium signaling pathway
mmur04024  cAMP signaling pathway
mmur04110  Cell cycle
mmur04310  Wnt signaling pathway
mmur04927  Cortisol synthesis and secretion
mmur04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system